Bio-Processing Alliance, Inc. (BPAI) has launched a biologics drug development consulting business to provide support the management of complex biologics programs from concept, through to development and Phase I-III trials.

BPAI’s goal is to assist innovator companies in the management of third-party service relationships using its CMO experience, technology transfer expertise, project management, process development and optimization, analytical development, scale-up, cGMP manufacturing, compliance and regulatory experience. BPAI’s founders formerly worked at QSV Biologics, which closed in 2009.

Click here to find out more about BPAI